|
2024
|
Invention
|
Morpholine orexin receptor antagonists. The present invention relates to compounds of Formula (I)... |
|
2023
|
Invention
|
Processes and intermediates for synthesising opicapone. The present invention relates to a method... |
|
|
Invention
|
Treatment regimens for early idiopathic parkinson's disease.
Opicapone for use as adjunctive the... |
|
|
Invention
|
Treatment regimens for parkinson's disease. A method of treating Parkinson's disease in a patient... |
|
|
Invention
|
Treatment regimens for early idiopathic parkinson's disease. Opicapone for use as adjunctive ther... |
|
|
Invention
|
Prodrugs of opicapone. This invention relates to prodrugs of opicapone, their synthetic intermedi... |
|
|
Invention
|
Medicaments for slowing parkinson's disease.
Opicapone, levodopa and an AADC inhibitor are descr... |
|
2022
|
Invention
|
Dopamine-b-hydroxylase inhibitors.
This invention relates to: (a) compounds of formula Ia (with ... |
|
|
Invention
|
Methods of treatment of partial onset seizures using eslicarbazepine acetate.
The present disclo... |
|
|
Invention
|
Nitrocatechol derivatives as comt inhibitors.
New compounds of formula I are described:
New co... |
|
|
G/S
|
Pharmaceutical preparations; Medical preparations; Veterinary preparations; Sanitary preparations... |
|
2021
|
Invention
|
Treatment regimens for parkinson's disease.
Opicapone, or a pharmaceutically acceptable derivati... |
|
|
Invention
|
Opicapone and levodopa for the treatment of parkinson's disease. Opicapone, or a pharmaceutically... |
|
|
Invention
|
Treatment of pain associated with parkinson's disease.
This invention relates to methods for tre... |
|
|
Invention
|
Solid dispersion of opicapone.
This invention relates to kinetically soluble and bioavailable fo... |
|
|
Invention
|
Solid dispersion of opicapone. This invention relates to kinetically soluble and bioavailable for... |
|
|
Invention
|
Tablet comprising opicapone.
The present invention provides a tablet comprising opicapone or a p... |
|
|
Invention
|
Tablet comprising opicapone. The present invention provides a tablet comprising opicapone or a ph... |
|
|
Invention
|
1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase.
Compounds ... |
|
|
Invention
|
Methods for the administration of comt inhibitors.
Provided are methods of administering a catec... |
|
|
Invention
|
Particle size control.
The present invention relates to micronised pharmaceutical products of cr... |
|
|
Invention
|
Micronised opicapone. The present invention relates to micronised pharmaceutical products of crys... |
|
|
Invention
|
Blood-brain barrier-penetrant dopamine-ß-hydroxylase inhibitors.
This invention relates to: (a) ... |
|
|
Invention
|
Pharmaceutical composition comprising licarbazepine acetate.
A pharmaceutical composition compri... |
|
|
Invention
|
Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa... |
|
2020
|
Invention
|
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same. ... |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE CENTRAL AND PERIPH... |
|
|
Invention
|
Methods of treatment of partial onset seizures using eslicarbazepine acetate. The present disclos... |
|
|
Invention
|
Dopamine-b-hydroxylase inhibitors.
This invention relates to: (a) compounds of formula I (with R... |
|
|
Invention
|
Dopamine-b-hydroxylase inhibitors. This invention relates to: (a) compounds of formula I (with R1... |
|
|
Invention
|
Dopamine-β-hydroxylase inhibitors. 155 and A as defined herein) and pharmaceutically acceptable s... |
|
|
G/S
|
Providing medical information |
|
|
Invention
|
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof.
... |
|
2019
|
Invention
|
Imidazolecarboxamides and their use as faah inhibitors.
A compound having a structure selected f... |
|
|
G/S
|
providing medical information |
|
|
G/S
|
Non-medicated cosmetics and toiletry preparations; Non-medicated dentifrices; Perfumery, essentia... |
|
|
Invention
|
Methods for the administration of comt inhibitors. Provided are methods of administering a catech... |
|
|
Invention
|
Processes for the synthesis of substituted urea compounds. 2R5 to form a glyoxal intermediate R6-... |
|
|
Invention
|
Formulations comprising dopamine-b-hydroxylase inhibitors and methods for their preparation.
The... |
|
|
Invention
|
Formulations comprising dopamine-beta-hydroxylase inhibitors and methods for their preparation. T... |
|
|
Invention
|
Formulations comprising dopamine-β-hydroxylase inhibitors and methods for their preparation. The ... |
|
2018
|
Invention
|
Dopamine-b-hydroxylase inhibitors. This invention relates to: (a) compounds of formula Ia (with R... |
|
|
G/S
|
Pharmaceuticals, medical and veterinary preparations;
sanitary preparations for medical purposes... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of diseases and disorders of the central and periph... |
|
|
G/S
|
Pharmaceutical, medical and veterinary preparations; Sanitary preparations for medical purposes;... |
|
2017
|
Invention
|
Dopamine-β-hydroxylase inhibitors. This invention relates to: (a) compounds of Formula Ia (with R... |
|
|
Invention
|
Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitors. 5, n and A as defined herein) an... |
|
|
G/S
|
Pharmaceutical and veterinary preparations for the treatment of diseases and disorders of the cen... |
|
2016
|
G/S
|
Pharmaceutical and veterinarian preparations; Sanitary preparations for medical purposes; Dieteti... |
|
2015
|
G/S
|
Printed materials, namely, periodicals, booklets, brochures, and pamphlets in the fields of disea... |
|
|
G/S
|
Pharmaceutical products and preparations for the treatment and prevention of diseases and conditi... |
|
|
G/S
|
Providing medical information relating to ongoing research programs and studies in the fields of ... |
|
2014
|
G/S
|
Pharmaceutical products and preparations in the nature of eslicarbazepine acetate for the treatme... |
|
2013
|
G/S
|
Pharmaceutical preparations for the treatment of central nervous system disorders |
|
2011
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic ... |
|
|
G/S
|
Pharmaceutical products for the diagnostic, prophylaxis and treatment of allergies; pharmaceutica... |
|
|
G/S
|
Pharmaceutical preparations; sanitary preparations for medical purposes; dietetic substances adap... |
